​

Sharps Stock (NASDAQ:STSS)

OwnershipFinancialsChart
Sharps by TradingView

Previous Close

$16.03

52W Range

$3.30 - $2.15K

50D Avg

$6.31

200D Avg

$202.10

Market Cap

$13.86M

Avg Vol (3M)

$1.87M

Beta

2.14

Div Yield

-

STSS Company Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

55

IPO Date

Apr 14, 2022

Website

STSS Performance

STSS Financial Summary

Dec 24Dec 23Dec 22
Revenue---
Operating Income$-9.63M$-10.13M$-8.74M
Net Income$-9.30M$-9.84M$779.88K
EBITDA$-9.63M$-8.98M$-2.66M
Basic EPS$-7.40$-0.76$0.10
Diluted EPS$-7.40$-0.76$0.10

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
HTCRHeartCore Enterprises, Inc.
POAIPredictive Oncology Inc.
NXGLNEXGEL, Inc.
PDEXPro-Dex, Inc.
SPRCSciSparc Ltd.
ACONAclarion, Inc.
GCTKGlucoTrack, Inc.
HSCSHeart Test Laboratories, Inc.